ODP247 The Detection of Metabolic Dysfunction–Associated Fatty Liver Disease via Fibroscan® in Early–to–Mid Pregnancy is an Independent Risk Factor for the Development of Gestational Diabetes Mellitus

AIMS: To investigate whether the detection of metabolic dysfunction–associated fatty liver disease (MAFLD), formerly known as non–alcoholic fatty liver disease (NAFLD), in early–to–mid pregnancy is associated with the development of gestational diabetes mellitus (GDM). METHODS: A prospective longitu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Thora Ying Li, Deng, Difei, George, Jacob, Pasupathy, Dharmintra, Cheung, Ngai Wah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Diabetes & Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624772/
http://dx.doi.org/10.1210/jendso/bvac150.695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624772/
http://dx.doi.org/10.1210/jendso/bvac150.695

Ejemplares similares